Skip to Content


Request To Amend a License To Export High-Enriched Uranium

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to 10 CFR 110.70(b)(2) “Public notice of receipt of an application,” please take notice that the Nuclear Regulatory Commission has received the following request to amend an export license. Copies of the request are available electronically through ADAMS and can be accessed through the Public Electronic Reading Room (PERR) link​reading-rm.html at the NRC Homepage.

A request for a hearing or petition for leave to intervene may be filed within 30 days after publication of this notice in the Federal Register. Any request for hearing or petition for leave to intervene shall be served by the requestor or petitioner upon the applicant, the Office of the General Counsel, U.S. Nuclear Regulatory Commission, Washington, DC 20555; the Secretary, U.S. Nuclear Regulatory Commission, Washington, DC 20555; and the Executive Secretary, U.S. Department of State, Washington, DC 20520.

In its review of the request to amend a license to export special nuclear material noticed herein, the Commission does not evaluate the health, safety or environmental effects in the recipient nation of the material to be exported. The information concerning this amendment request follows. Start Printed Page 56392

NRC Export License Application for High-Enriched Uranium

Name of applicant, date of application, date received, application No., docket No.Description of materialDescription of amendment end useCountry of destination
Material typeTotal qty
Transnuclear, Inc., September 18, 2007, September 20, 2007, XSNM03060/03, 11005070High-Enriched Uranium (HEU) (93.60%)Total quantity of HEU authorized for export remains unchangedLicense is amended to: (1) transfer the current license from Transnuclear, Inc. to BWXT NOD-L as licensee; (2) remove BWXT and insert DOE/NNSA and BWXT Y-12, LLC as “Other Parties to Export”; and (3) extend the license expiration date from 12/31/07 to 12/31/12 HEU is used to produce medical radioisotopesCanada.
Start Signature

Dated this 27th day of September 2007 at Rockville, Maryland.

For the U.S. Nuclear Regulatory Commission.

Scott W. Moore,

Deputy Director, Office of International Programs.

End Signature End Preamble

[FR Doc. E7-19492 Filed 10-2-07; 8:45 am]